GlassScriptPhysician profile
April E Reagan
NPI 1043330475
$1,147.66
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $72.75 · 2022: $754 · 2023: $190 · 2024: $131.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $321.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $320.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $195.65 | 2022-2023 | |
| Abbvie INC. | $151.64 | 2021-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $139.98 | 2021-2023 | |
| Gilead Sciences, INC. | $130.78 | 2024 | Trodelvy |
| Agile Therapeutics, INC. | $104.76 | 2021-2023 | Twirla |
| Avion Pharmaceuticals | $78.46 | 2022 | |
| Organon LLC | $63.83 | 2022-2023 | Nexplanon |
| Myovant Sciences INC. | $61.40 | 2022 | |
| Scynexis, INC. | $57.66 | 2022 | |
| Pfizer INC. | $32.71 | 2022-2023 | |
| Exeltis, USA INC. | $31.23 | 2022 | |
| Hologic Sales and Service, LLC | $18.81 | 2022 | |
| Davol INC. | $18.08 | 2023 | Arista Ah Flexitip |
| Exact Sciences Corporation | $16.74 | 2023 | Cologuard Collection Kit |
| Edwards Lifesciences Corporation | $15.95 | 2023 | Hemosphere |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medicem INC. | $15.63 | 2022 | |
| Sumitomo Pharma America, INC. | $14.35 | 2023 | Myfembree |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw April Reagan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.